. Rational Design of Novel 1,3-Oxazine Based β-Secretase (BACE1) Inhibitors: Incorporation of a Double Bond To Reduce P-gp Efflux Leading to Robust Aβ Reduction in the Brain. J Med Chem. 2018 Jun 28;61(12):5122-5137. Epub 2018 May 23 PubMed.


Please login to recommend the paper.


No Available Comments

Make a Comment

To make a comment you must login or register.